All Articles

As TE Connectivity preps its Q3 results, its performance offers a crucial look into the real-world build-out of AI, EVs, and automated factories.

As biotech firm Seer secures key patent wins, it's not just defending its tech—it's drawing the battle lines for the multi-billion dollar proteomics market.

With new high-capacity platforms and liquid cooling, DriveNets is betting its open architecture can solve the AI networking bottleneck and undercut proprietary rivals.

The beloved series lands on a new platform, but the real story is a masterclass in digital strategy and the new rules of the booming audiobook market.

Scale Computing's new CCO role for DeWayne Mangan reveals a strategy to make unified technical support its key differentiator in the competitive edge market.

As AI's energy thirst strains public grids, a $1.75B deal creates a private power giant. Is this the future of innovation or a new era of energy inequity?

As M&A devours the wealth management landscape, one firm is making a different bet. We deconstruct why NBC Securities' rebrand to Lanark Financial is more than a name change—it's a strategic declaration.

A Singapore-based company has patented a device to end large incisions in colorectal surgery, promising fewer infections and faster patient recovery.

Amid a tough fundraising climate, Hamilton Lane's record fund close reveals a key strategy for 2026: the enduring power of the middle-market buyout.

With €7.5M from Europe’s top innovation fund, a Belgian startup is not just correcting vision—it’s turning the eye into a window for our overall health.

The university that gave football the huddle now partners with Nike. This historic deal is more than gear—it's a strategic play for visibility and inclusion.

Dove's partnership with Prime Video's 'Elle' is more than product placement. It's a masterclass in leveraging nostalgia and integrated streaming content.

A deep dive into why a blue-chip REIT hired a tech visionary, and what it signals about the future of AI in the multi-billion dollar retail property market.

STARMED secures a landmark FDA clearance for its thyroid RFA system, the first of its kind, promising a minimally invasive alternative to surgery.

Intensity Therapeutics shows promising results for its cancer-killing drug, but can it navigate the biotech funding crunch and land a vital pharma partner?

In a market frozen by high rates, Starwood Capital's massive new fund signals a strategic hunt for distress and a pivot to digital economy real estate.

A top general warns of 'AI dominance.' See how Chandigarh University is answering the call by embedding tech giants into its DNA to build a future-proof workforce.

OneCompass Holdings appoints commercialization expert Ryan Bleeks to lead Aquinas, signaling a strategic push into tech-driven pharmaceutical training.

RPM International just marked 52 years of rising dividends. We look past the numbers to reveal the strategy and discipline behind this rare corporate feat.